Fuselier H A, Guice S L, Brannan W, Ochsner M G, Sangisetty K V, Beckman E N, Barnes C A
J Urol. 1983 Sep;130(3):445-8. doi: 10.1016/s0022-5347(17)51243-4.
We reviewed 161 patients operated upon for renal cell carcinoma between 1945 and 1978. Life table and survival analyses were computed to compare the effects of stage, tumor differentiation, cell type, surgical technique, renal vein involvement and sex on the years of survival. Patients with stage I and well differentiated tumors had the best prognosis. All patients surviving 10 years or more had well differentiated tumors. The type of nephrectomy did not affect survival and lymphadenectomy was only of value in staging the disease. The stage and differentiation of the tumor were more important to outcome than choice of therapy.
我们回顾了1945年至1978年间接受肾细胞癌手术的161例患者。计算生命表和生存分析,以比较分期、肿瘤分化、细胞类型、手术技术、肾静脉受累情况和性别对生存年限的影响。I期和高分化肿瘤患者的预后最佳。所有存活10年或更长时间的患者都有高分化肿瘤。肾切除术的类型不影响生存,而淋巴结切除术仅在疾病分期方面有价值。肿瘤的分期和分化对预后比治疗选择更重要。